News related to Copaxone (Glatiramer) and/or conditions it is approved for
Multiple Sclerosis More Common In Black Women Than White
Source: Multiple Sclerosis News From Medical News Today [2013.05.07]
Multiple sclerosis (MS) is more common in black women than in white women, according a new study. The research was conducted by Kaiser Permanente and was published in the journal Neurology. The results contradict the widely believed notion that black people are less vulnerable to the disease. The electronic health records of over 3...
Peli1 Identified As Pivotal Actor In Animal Model Of Multiple Sclerosis
Source: Multiple Sclerosis News From Medical News Today [2013.05.06]
Scientists have identified an influential link in a chain of events that leads to autoimmune inflammation of the central nervous system in a mouse model of multiple sclerosis (MS). An international team of researchers led by scientists in The University of Texas MD Anderson Cancer Center Department of Immunology reported their results in an advance online publication in Nature Medicine...
Atrophy In Key Region Of Brain Associated With Multiple Sclerosis
Source: Multiple Sclerosis News From Medical News Today [2013.04.25]
Magnetic resonance imaging (MRI) measurements of atrophy in an important area of the brain are an accurate predictor of multiple sclerosis (MS), according to a new study published online in the journal Radiology. According to the researchers, these atrophy measurements offer an improvement over current methods for evaluating patients at risk for MS...
Shrinkage of Brain Region May Signal Onset of Multiple Sclerosis
Source: MedicineNet Multiple Sclerosis Specialty [2013.04.23]
Title: Shrinkage of Brain Region May Signal Onset of Multiple Sclerosis
Category: Health News
Created: 4/23/2013 10:35:00 AM
Last Editorial Review: 4/23/2013 12:00:00 AM
Multiple Sclerosis
Source: MedicineNet Amyotrophic Lateral Sclerosis Specialty [2013.04.16]
Title: Multiple Sclerosis
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 4/16/2013 12:00:00 AM
New Technique Holds Promise For The Treatment Of Multiple Sclerosis And Cerebral Palsy
Source: Multiple Sclerosis News From Medical News Today [2013.04.15]
Researchers at Case Western Reserve School of Medicine have discovered a technique that directly converts skin cells to the type of brain cells destroyed in patients with multiple sclerosis, cerebral palsy and other so-called myelin disorders. This discovery appears in the journal Nature Biotechnology...
Study Of Amyloid-Forming Proteins May Lead To Therapies For Multiple Sclerosis, Other Neurodegenerative Diseases
Source: Multiple Sclerosis News From Medical News Today [2013.04.05]
Amyloids - clumps of misfolded proteins found in the brains of people with Alzheimer's disease and other neurodegenerative disorders - are the quintessential bad boys of neurobiology...
Hunger-Spiking Neurons May Control Multiple Sclerosis And Other Autoimmune Diseases
Source: Multiple Sclerosis News From Medical News Today [2013.03.29]
If appetite-promoting AgRP neurons are chronically suppressed, resulting in less appetite and a lighter body weight, T-cells tend to promote inflammation-like processes resulting in autoimmune responses that may lead to multiple sclerosis and other autoimmune diseases, scientists at Yale School of Medicine discovered...
Bone Marrow Transplant Treatment Risky But Effective For Multiple Sclerosis
Source: Multiple Sclerosis News From Medical News Today [2013.03.29]
A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS...
Tecfidera Approved For Multiple Sclerosis By FDA
Source: Multiple Sclerosis News From Medical News Today [2013.03.29]
Tecfidera (dimethyl fumarate) capsules have just been approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsing forms of multiple sclerosis (MS). MS is an autoimmune disease of the central nervous system that is known for being persistent and inflammatory...
Tecfidera Approved for Multiple Sclerosis
Source: MedicineNet Multiple Sclerosis Specialty [2013.03.29]
Title: Tecfidera Approved for Multiple Sclerosis
Category: Health News
Created: 3/28/2013 12:35:00 PM
Last Editorial Review: 3/29/2013 12:00:00 AM
FDA Approves New Multiple Sclerosis Drug
Source: MedicineNet Multiple Sclerosis Specialty [2013.03.28]
Title: FDA Approves New Multiple Sclerosis Drug
Category: Health News
Created: 3/28/2013 10:35:00 AM
Last Editorial Review: 3/28/2013 12:00:00 AM
Multiple Sclerosis, Other Autoimmune Diseases May Be Controlled By Hunger-Spiking Neurons
Source: Multiple Sclerosis News From Medical News Today [2013.03.27]
Neurons that control hunger in the central nervous system also regulate immune cell functions, implicating eating behavior as a defense against infections and autoimmune disease development, Yale School of Medicine researchers have found in a new study published in the Proceedings of the National Academy of Sciences (PNAS). Autoimmune diseases have been on a steady rise in the United States...
Focus On The Thalamus In Multiple Sclerosis Research
Source: Multiple Sclerosis News From Medical News Today [2013.03.26]
A growing body of research by multiple sclerosis (MS) investigators at the University at Buffalo and international partners is providing powerful new evidence that the brain's gray matter reflects important changes in the disease that could allow clinicians to diagnose earlier and to better monitor and predict how the disease will progress...
Gilenya® (Fingolimod) Demonstrates Consistent Benefits In Reduction Of Relapses And Brain Volume Loss In Relapsing-Remitting Multiple Sclerosis
Source: Multiple Sclerosis News From Medical News Today [2013.03.25]
Data presented at the 65th annual meeting of the American Academy of Neurology (AAN) show Gilenya® (fingolimod), the first and only once-daily oral therapy reimbursed to treat highly active relapsing-remitting multiple sclerosis (RRMS), significantly and consistently reduced the rate of brain volume loss and reduced relapse rates compared to interferon beta-1a IM or placebo...
Promising Target Identified For Multiple Sclerosis Treatments
Source: Multiple Sclerosis News From Medical News Today [2013.03.21]
A team of basic and clinical scientists led by the University of Montreal Hospital Research Centre's (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis (MS)...
Multiple Sclerosis And Stroke Findings In Rehabilitation Research
Source: Multiple Sclerosis News From Medical News Today [2013.03.19]
Kessler Foundation scientists and their colleagues will discuss their progress in rehabilitation research at the upcoming 65th Annual American Academy of Neurology Conference at the San Diego Convention Center in San Diego, CA, March 16 - 23. A.M...
Botox May Ease Tremors in Multiple Sclerosis Patients
Source: MedicineNet Wrinkles Specialty [2012.07.03]
Title: Botox May Ease Tremors in Multiple Sclerosis Patients
Category: Health News
Created: 7/2/2012 6:05:00 PM
Last Editorial Review: 7/3/2012 12:00:00 AM
Breakthrough Marks The First Time Human Stem Cells Have Been Produced Via Nuclear Transfer
Source: Health News from Medical News Today [2013.05.17]
Scientists at Oregon Health & Science University and the Oregon National Primate Research Center (ONPRC) have successfully reprogrammed human skin cells to become embryonic stem cells capable of transforming into any other cell type in the body. It is believed that stem cell therapies hold the promise of replacing cells damaged through injury or illness. Diseases or conditions that might be treated through stem cell therapy include Parkinson's disease, multiple sclerosis, cardiac disease and spinal cord injuries. The research breakthrough, led by Shoukhrat Mitalipov, Ph.D...
How Nerve Wiring Self-Destructs Has Relevance To Diseases Of Peripheral And Central Nervous Systems
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.05.13]
Many medical issues affect nerves, from injuries in car accidents and side effects of chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the long wires that transmit signals to other parts of the body, allowing movement, sight and sense of touch, among other vital functions...
PML Reported in Europe with Fumarate (CME/CE)
Source: MedPage Today Dermatology [2013.04.24]
(MedPage Today) -- Two cases of progressive multifocal leukoencephalopathy (PML) have been reported in patients treated with oral dimethyl fumarate, a form of which won FDA approval last month for multiple sclerosis.
Data Gathered Reveals Extent Of Alternative Medicine Use By MS Patients
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2013.04.23]
A major Nordic research project involving researchers from the University of Copenhagen has, for the first time ever, mapped the use of alternative treatment among multiple sclerosis patients - knowledge which is important for patients with chronic disease and the way in which society meets them...
Acorda's MS Drug Ampyra Helps Stroke Patients Walk
Source: Stroke News From Medical News Today [2013.04.15]
An Acorda Therapeutics drug, Ampyra (dalfampridine), which helps people with multiple sclerosis walk, also helps stroke patients who cannot walk, the company announced. In a proof-of- concept Phase II study, Ampyra (dalfampridine extended release 10mg tablets) significantly improved walking in patients with post-stroke deficits...
Effect Of Genzyme's LEMTRADA Maintained In Patients Beyond Two-Year Pivotal MS Studies
Source: Multiple Sclerosis News From Medical News Today [2013.03.28]
In more than 70 percent of patients, disability scores improved or remained stable over three years Genzyme, a Sanofi Company (EURONEXT: SAN and NYSE: SNY), have announced interim results from the first year of the extension study of LEMTRADA™ (alemtuzumab), being developed for the treatment for multiple sclerosis (MS)...
Has Natural Selection Caused Inflammatory Disease?
Source: Multiple Sclerosis News From Medical News Today [2013.03.26]
In new research published in the April 4, 2013 issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital (BWH) demonstrate that some variants in our genes that could put a person at risk for inflammatory diseases such as multiple sclerosis, Crohn's disease or rheumatoid arthritis, have been the target of natural selection over the course of human history...
Excellent Results For MS Drug "Plegridy"
Source: Clinical Trials / Drug Trials News From Medical News Today [2013.03.21]
Biogen Idec has just announced its final first year results of the Phase 3 trial of its relapsing-remitting multiple sclerosis drug Plegridy (peginterferon beta-1a). The drug met all primary and secondary endpoints of the trial results indicating that it is very effective at reducing multiple sclerosis (MS) disease activity...
Early Identification Of Disease Via New MRI Fingerprint Method
Source: MRI / PET / Ultrasound News From Medical News Today [2013.03.15]
A new method of magnetic resonance imaging (MRI) could routinely spot specific cancers, multiple sclerosis, heart disease and other maladies early, when they're most treatable, researchers at Case Western Reserve University and University Hospitals (UH) Case Medical Center suggest in the journal Nature...
|
